Sprint Bioscience AB (publ)

OM:SPRINT Stock Report

Market Cap: SEK 356.6m

Sprint Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:SPRINT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Dec 25BuySEK 43,500Bjorn SjostrandIndividual30,000SEK 1.45
01 Dec 25BuySEK 38,962Johan EmilssonIndividual23,750SEK 1.64
28 Nov 25BuySEK 95,364Bjorn SjostrandIndividual59,980SEK 1.60

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SPRINT?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms9,907,4719.39%
Institutions12,706,50312%
Individual Insiders24,988,48723.7%
General Public57,913,07754.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 12 shareholders own 45.11% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.99%
Rune Nordlander
10,541,082SEK 35.6m0%no data
9.39%
First Venture Sweden AB (publ)
9,907,471SEK 33.5m0%70.18%
7.37%
Nordnet Pensionsförsäkring AB
7,776,110SEK 26.3m0%0.26%
6.59%
Jan Nordqvist
6,953,280SEK 23.5m0%no data
5.67%
Mats Westinius
5,985,000SEK 20.2m0%no data
4.67%
Avanza Fonder AB
4,930,393SEK 16.7m0%0.02%
0.89%
Bjorn Sjostrand
942,334SEK 3.2m0%no data
0.26%
Martin Andersson
273,742SEK 925.2k0%no data
0.17%
Anne-Marie Wenthzel
178,049SEK 601.8k0%no data
0.047%
Fredrik Lehmann
50,000SEK 169.0k0%no data
0.043%
Svein Mathisen
45,000SEK 152.1k0%no data
0.019%
Johan Emilsson
20,000SEK 67.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 17:40
End of Day Share Price 2026/06/10 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sprint Bioscience AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Siri LadowDanske Bank
Fredrik ThorRedeye